
Sign up to save your podcasts
Or


Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.52 AANP including 0.52 AANP Pharm
Overview: Explore the evolving role of post-exposure prophylaxis (PEP) for COVID-19 in high-risk populations. Join infectious disease experts from Johns Hopkins as they discuss the latest data, clinical considerations, and promising agents in reducing severe outcomes when vaccination alone may not be enough.
By Pri-Med4.5
8585 ratings
Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.52 AANP including 0.52 AANP Pharm
Overview: Explore the evolving role of post-exposure prophylaxis (PEP) for COVID-19 in high-risk populations. Join infectious disease experts from Johns Hopkins as they discuss the latest data, clinical considerations, and promising agents in reducing severe outcomes when vaccination alone may not be enough.

134 Listeners

709 Listeners

503 Listeners

261 Listeners

299 Listeners

266 Listeners

3,376 Listeners

1,140 Listeners

194 Listeners

90 Listeners

521 Listeners

367 Listeners

250 Listeners

376 Listeners

320 Listeners